Edward M. Schaeffer

21.7k citations

294 papers · 9.4k indexed · 3 hit papers · h-index 50

Impact in

Pulmonary and Respiratory Medicine top 0.2%
- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment
Cancer Research top 0.5%
- Cancer, Lipids, and Metabolism

Papers in

Pulmonary and Respiratory Medicine 228
- Prostate Cancer Treatment and Research 177
- Prostate Cancer Diagnosis and Treatment 156
Urology 20

Co-authors: Ashley E. Ross Stacy Loeb Pamela L. Schwartzberg Alan W. Partin Debasish Sundi Winnie Ricker Sonja I. Berndt H. Ballentine Carter
Journals: The Journal of Urology (46 papers)Journal of Clinical Oncology (34 papers)Urology (29 papers)Prostate Cancer and Prostatic Diseases (19 papers)European Urology (15 papers)
Partner nations: United States Canada United Kingdom

In The Last Decade

Edward M. Schaeffer

281 papers receiving 9.3k citations

Hit Papers

align trajectories log scale

Complications After Systematic, Random, and Image-guided Prostate Biopsy 2016 · 346 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2016 European Urology
2011 The Journal of Urology
2000 Nature

Peers

Countries citing papers authored by Edward M. Schaeffer

Since Specialization

Citations

This map shows the geographic impact of Edward M. Schaeffer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward M. Schaeffer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward M. Schaeffer more than expected).

Fields of papers citing papers by Edward M. Schaeffer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edward M. Schaeffer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward M. Schaeffer. The network helps show where Edward M. Schaeffer may publish in the future.

Co-authors

The 25 scholars most cited alongside Edward M. Schaeffer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Edward M. Schaeffer Line = papers co-authored together Edward M. Schaeffer links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Utility of 18F-DCFPyL PET for local staging for high or very high risk prostate cancer for patients undergoing radical prostatectomy European Journal of Nuclear Medicine and Molecular Imaging ·Eric V. Li, Edward M. Schaeffer, Sai Kaushik Shankar Ramesh Kumar, Ruoji Zhou, Ximing J. Yang, Margarita Mana-ay, Mariavittoria Vescovo, Austin Ho, Mary Kate Keeter, James E. Carr, David D. Casalino, Masha Kocherginsky, Hiten D. Patel, Ashley E. Ross, Hatice Savas	2025	2
2	Evaluating PI-RADS lesions and clinically significant prostate cancer in Black and Asian men: a PREVENT randomized clinical trial secondary analysis Prostate Cancer and Prostatic Diseases ·Conor Driscoll, Nicole Handa, Mitchell M. Huang, Adam B. Murphy, Jim C. Hu, Edward M. Schaeffer	2025	0
3	Androgen receptor–regulated lncRNA PRCAT71 promotes AR signaling through the interaction with KHSRP in prostate cancer Science Advances ·Yongyong Yang, Ting-You Wang, Qianru Li, Jiawen Lu, Yanan Ren, Adam B. Weiner, Joshua Fry, Qi Liu, Chaehyun Yum, Rui Wang, Qingxiang Guo, Yu Wan, Zhe Ji, Xuesen Dong, Tamara L. Lotan, Edward M. Schaeffer, Rendong Yang, Qi Cao	2025	0
4	Testosterone recovery after androgen deprivation therapy Urologic Oncology Seminars and Original Investigations ·Austin Ho, Eric V. Li, Richard G. Bennett, Chalairat Suk‐Ouichai, Sai Kaushik Shankar Ramesh Kumar, Clayton Neill, Yutai Li, Edward M. Schaeffer, Alicia K. Morgans, Hiten D. Patel, Ashley E. Ross	2024	1
5	Prostate Cancer Risk Stratification in NRG Oncology Phase III Randomized Trials Using Multimodal Deep Learning With Digital Histopathology JCO Precision Oncology ·Jonathan D. Tward, Huei–Chung Huang, Andre Esteva, Osama Mohamad, Douwe van der Wal, Jeffry Simko, Sandy DeVries, Jingbin Zhang, Songwan Joun, Timothy N. Showalter, Edward M. Schaeffer, Todd M. Morgan, Jedidiah M. Monson, James A. Wallace, Jean-Paul Bahary, Howard M. Sandler, Daniel E. Spratt, Joseph P. Rodgers, Felix Y. Feng, Phuoc T. Tran	2024	5
6	Mechanism-centric regulatory network identifies NME2 and MYC programs as markers of Enzalutamide resistance in CRPC Nature Communications ·Sukanya Panja, Mihai I. Truica, Christina Y. Yu, Vamshi Saggurthi, Michael W. Craige, Katie Whitehead, Mayra Vendramini Tuiche, Aymen Al-Saadi, Riddhi Vyas, Shridar Ganesan, Suril Gohel, Frederick D. Coffman, J. Scott Parrott, Songhua Quan, Shantenu Jha, Isaac Kim, Edward M. Schaeffer, Vishal Kothari, Sarki A. Abdulkadir, Antonina Mitrofanova	2024	9
7	Risk Stratification of Patients with Recurrence After Primary Treatment for Prostate Cancer: A Systematic Review European Urology ·Adam B. Weiner, Preeti Kakani, Andrew J. Armstrong, Alberto Bossi, Philip Cornford, Felix Y. Feng, Pratik Kanabur, R. Jeffery Karnes, Rana R. McKay, Todd M. Morgan, Edward M. Schaeffer, Neal D. Shore, Alison Tree, Daniel E. Spratt	2024	13
8	Detection of clinically significant prostate cancer following initial omission of biopsy in multiparametric MRI era Prostate Cancer and Prostatic Diseases ·Eric V. Li, Anna Busza, Mohammad R. Siddiqui, Jonathan Aguiar, Mary-Kate Keeter, Clayton Neill, Sai Kumar, Xinlei Mi, Edward M. Schaeffer, Hiten D. Patel, Ashley E. Ross	2024	2
9	Comparison of Multiple Segmentation Methods for Volumetric Delineation of Primary Prostate Cancer with Prostate-Specific Membrane Antigen–Targeted¹⁸F-DCFPyL PET/CT Journal of Nuclear Medicine ·Felicia Wang, Chen Liu, Igor Vidal, Margarita Mana-ay, Andrew F. Voter, Lilja B. Sólnes, Ashley E. Ross, Andrei Gafita, Edward M. Schaeffer, Trinity J. Bivalacqua, Kenneth J. Pienta, Martin G. Pomper, Martin A. Lodge, Daniel Y. Song, Jorge D. Oldan, Mohamad E. Allaf, Angelo M. De Marzo, Sara Sheikhbahaei, Michael A. Gorin, Steven P. Rowe	2023	6
10	Association of B7‐H3 expression with racial ancestry, immune cell density, and androgen receptor activation in prostate cancer Cancer ·Adrianna A. Mendes, Jiayun Lu, Harsimar Kaur, Siqun L. Zheng, Jianfeng Xu, Jessica Hicks, Adam B. Weiner, Edward M. Schaeffer, Ashley E. Ross, Steven P. Balk, Mary‐Ellen Taplin, Nathan A. Lack, Emirhan Tekoglu, Janielle P. Maynard, Angelo M. De Marzo, Emmanuel S. Antonarakis, Karen S. Sfanos, Corinne E. Joshu, Eugene Shenderov, Tamara L. Lotan	2022	18
11	CDKN1B Deletions are Associated with Metastasis in African American Men with Clinically Localized, Surgically Treated Prostate Cancer Clinical Cancer Research ·Farzana A. Faisal, Sanjana Murali, Harsimar Kaur, Thiago Vidotto, Liana B. Guedes, Daniela C. Salles, Vishal Kothari, Jeffrey J. Tosoian, Sumin Han, Daniel H. Hovelson, Kevin Hu, Daniel E. Spratt, Alexander S. Baras, Scott A. Tomlins, Edward M. Schaeffer, Tamara L. Lotan	2020	23
12	Changes in prostate‐specific antigen at the time of prostate cancer diagnosis after Medicaid expansion in young men Cancer ·Adam B. Weiner, Amanda X. Vo, Anuj S. Desai, Jim C. Hu, Daniel E. Spratt, Edward M. Schaeffer	2020	10
13	TWIST1-WDR5- Hottip Regulates Hoxa9 Chromatin to Facilitate Prostate Cancer Metastasis Cancer Research ·Reem Malek, Rajendra P. Gajula, Russell D. Williams, Belinda Nghiem, Brian W. Simons, Katriana Nugent, Hailun Wang, Kekoa Taparra, Ghali Lemtiri-Chlieh, A‐Rum Yoon, Lawrence D. True, Steven S. An, Theodore L. DeWeese, Ashley E. Ross, Edward M. Schaeffer, Kenneth J. Pienta, Paula J. Hurley, Colm Morrissey, Phuoc T. Tran	2017	93
14	Analytic, Preanalytic, and Clinical Validation of p53 IHC for Detection of TP53 Missense Mutation in Prostate Cancer Clinical Cancer Research ·Liana B. Guedes, Fawaz Almutairi, Michael C. Haffner, Gaurav Rajoria, Zach Liu, Szczepan Klimek, Roberto Zoino, Kasra Yousefi, Rajni Sharma, Angelo M. De Marzo, George J. Netto, William B. Isaacs, Ashley E. Ross, Edward M. Schaeffer, Tamara L. Lotan	2017	62
15	Integrated Classification of Prostate Cancer Reveals a Novel Luminal Subtype with Poor Outcome Cancer Research ·Sungyong You, Beatrice S. Knudsen, Nicholas Erho, Mohammed Alshalalfa, Mandeep Takhar, Hussam Al-Deen Ashab, Elai Davicioni, R. Jeffrey Karnes, Eric A. Klein, Robert B. Den, Ashley E. Ross, Edward M. Schaeffer, Isla P. Garraway, Jayoung Kim, Michael R. Freeman	2016	132
16	The Landscape of Prognostic Outlier Genes in High-Risk Prostate Cancer Clinical Cancer Research ·Shuang G. Zhao, Joseph R. Evans, Vishal Kothari, Grace Y. Sun, Ashley Larm, Victor Mondine, Edward M. Schaeffer, Ashley E. Ross, Eric A. Klein, Robert B. Den, Adam P. Dicker, R. Jeffrey Karnes, Nicholas Erho, Paul L. Nguyen, Elai Davicioni, Felix Y. Feng	2015	43
17	Bacterial Prostatitis Enhances 2-Amino-1-Methyl-6-Phenylimidazo[4,5- b ]Pyridine (PhIP)–Induced Cancer at Multiple Sites Cancer Prevention Research ·Karen S. Sfanos, Kirstie Canene‐Adams, Heidi Hempel, Shu-Han Yu, Brian W. Simons, Anthony J. Schaeffer, Edward M. Schaeffer, William G. Nelson, Angelo M. De Marzo	2015	18
18	Androgen-Regulated SPARCL1 in the Tumor Microenvironment Inhibits Metastatic Progression Cancer Research ·Paula J. Hurley, Robert M. Hughes, Brian W. Simons, Jessie Huang, Rebecca M. Miller, Brian Shinder, Michael C. Haffner, David Esopi, Yasunori Kimura, Javaneh Jabbari, Ashley E. Ross, Nicholas Erho, Ismael A. Vergara, Sheila F. Faraj, Elai Davicioni, George J. Netto, Srinivasan Yegnasubramanian, Steven S. An, Edward M. Schaeffer	2015	22
19	African American Men With Very Low–Risk Prostate Cancer Exhibit Adverse Oncologic Outcomes After Radical Prostatectomy: Should Active Surveillance Still Be an Option for Them? Journal of Clinical Oncology ·Debasish Sundi, Ashley E. Ross, Elizabeth B. Humphreys, Misop Han, Alan W. Partin, H. Ballentine Carter, Edward M. Schaeffer	2013	176
20	Cancer after bone marrow transplantation. Site cant be reached ·(unknown), W Guenther, Thomas Duell, Gèrard Socié, Edward M. Schaeffer, Ernst Holler, Max A. Schumm, Mary M. Horowitz, Robert Peter Gale, (unknown)	1992	3

About Edward M. Schaeffer

Edward M. Schaeffer is a scholar working on Pulmonary and Respiratory Medicine, Urology, Cancer Research, Oncology and Rheumatology, having authored 294 papers that have together received 9.4k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (177 papers), Prostate Cancer Diagnosis and Treatment (156 papers), Cancer, Lipids, and Metabolism (31 papers), Urologic and reproductive health conditions (25 papers), Bladder and Urothelial Cancer Treatments (24 papers), Global Cancer Incidence and Screening (21 papers), Genital Health and Disease (19 papers) and Cancer Immunotherapy and Biomarkers (14 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (5.7k citations), Cancer Research (1.7k citations), Oncology (2.0k citations), Urology (460 citations) and Immunology (1.5k citations). Edward M. Schaeffer has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Ashley E. Ross, Stacy Loeb, Pamela L. Schwartzberg, Alan W. Partin, Debasish Sundi, Winnie Ricker, Sonja I. Berndt, H. Ballentine Carter, Dan R. Littman and Adam B. Weiner. Their work appears in journals such as The Journal of Urology, Journal of Clinical Oncology, Urology, Prostate Cancer and Prostatic Diseases and European Urology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact